Akebia Therapeutics Inc (AKBA)
1.25
+0.81%
Akebia Therapeutics Inc (AKBA) is currently trading at $1.25. This represents a gain of 0.81% from the previous session. With a market capitalization of $0.33B, AKBA is a key component of the Health Care sector. Investors looking to trade AKBA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade AKBA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Akebia Therapeutics Inc (AKBA) shows a bullish trend. Analysts are watching the 1.27 level closely.
Fundamentals
Mkt Cap0.33B
P/E Ratio0.0000
Volume90,407
60-Day Technical Chart
Advanced Charting
Need more indicators for AKBA? Use the world's #1 platform.
Open AKBA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $1
| Metric |
AKBA +0.81% |
AMC +2.14% |
HUMA +4.91% |
CGC +1.74% |
|---|---|---|---|---|
| Price | $1.25 | $1.20 | $1.18 | $1.20 |
| Mkt Cap | $0.33B | $0.63B | $0.23B | $0.66B |
| - | View → | View → | View → |
Latest Headlines
BTIG Research Has Lowered Expectations for Akebia Therapeutics (NASDAQ:AKBA) Stock Price
MarketBeat • Feb 25, 2026
BTIG Maintains Buy Rating on AKBA, Lowers Price Target by 20% |
GuruFocus • Feb 25, 2026
Akebia schedules Feb. 26 webcast on 2025 results, recent moves
Stock Titan • Feb 19, 2026
Akebia Therapeutics to Report Fourth Quarter and Full Year
GlobeNewswire • Feb 19, 2026
Akebia Therapeutics (AKBA) Loses 39.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance • Nov 11, 2025
● Gemini Agentic AI Analyst Insight for AKBA
Market Education
- What Wolves Can Teach Us About Winning in the Markets Sep 8, 2025
- What do these rich Traders do - Peek into their day Jul 15, 2023
- The Basics of the Stock Market for Beginners Aug 25, 2023
External Research